181 related articles for article (PubMed ID: 26547013)
1. The Prevalence of Stages of Heart Failure in Primary Care: A Population-Based Study.
Jorge AL; Rosa ML; Martins WA; Correia DM; Fernandes LC; Costa JA; Moscavitch SD; Jorge BA; Mesquita ET
J Card Fail; 2016 Feb; 22(2):153-7. PubMed ID: 26547013
[TBL] [Abstract][Full Text] [Related]
2. How B-Type Natriuretic Peptide (BNP) and Body Weight Changes Vary in Heart Failure With Preserved Ejection Fraction Compared With Reduced Ejection Fraction: Secondary Results of the HABIT (HF Assessment With BNP in the Home) Trial.
Maisel AS; Shah KS; Barnard D; Jaski B; Frivold G; Marais J; Azer M; Miyamoto MI; Lombardo D; Kelsay D; Iqbal N; Taub PR; Kupfer K; Lee E; Clopton P; Zile M; Greenberg B
J Card Fail; 2016 Apr; 22(4):283-93. PubMed ID: 26433086
[TBL] [Abstract][Full Text] [Related]
3. Comparable prognostic impact of BNP levels among HFpEF, Borderline HFpEF and HFrEF: a report from the CHART-2 Study.
Kasahara S; Sakata Y; Nochioka K; Yamauchi T; Onose T; Tsuji K; Abe R; Oikawa T; Sato M; Aoyanagi H; Miura M; Shiroto T; Takahashi J; Miyata S; Shimokawa H;
Heart Vessels; 2018 Sep; 33(9):997-1007. PubMed ID: 29569034
[TBL] [Abstract][Full Text] [Related]
4. Depressive symptoms are common and associated with adverse clinical outcomes in heart failure with reduced and preserved ejection fraction.
Kato N; Kinugawa K; Shiga T; Hatano M; Takeda N; Imai Y; Watanabe M; Yao A; Hirata Y; Kazuma K; Nagai R
J Cardiol; 2012 Jul; 60(1):23-30. PubMed ID: 22445598
[TBL] [Abstract][Full Text] [Related]
5. Growth differentiation factor 15, ST2, high-sensitivity troponin T, and N-terminal pro brain natriuretic peptide in heart failure with preserved vs. reduced ejection fraction.
Santhanakrishnan R; Chong JP; Ng TP; Ling LH; Sim D; Leong KT; Yeo PS; Ong HY; Jaufeerally F; Wong R; Chai P; Low AF; Richards AM; Lam CS
Eur J Heart Fail; 2012 Dec; 14(12):1338-47. PubMed ID: 22869458
[TBL] [Abstract][Full Text] [Related]
6. Accuracy of tissue Doppler echocardiography in the diagnosis of new-onset congestive heart failure in patients with levels of B-type natriuretic peptide in the midrange and normal left ventricular ejection fraction.
Arques S; Roux E; Sbragia P; Pieri B; Gelisse R; Ambrosi P; Luccioni R
Echocardiography; 2006 Sep; 23(8):627-34. PubMed ID: 16970713
[TBL] [Abstract][Full Text] [Related]
7. Different implication of elevated B-type natriuretic peptide level in patients with heart failure with preserved ejection fraction and in those with reduced ejection fraction.
Ishigaki T; Yoshida T; Izumi H; Fujisawa Y; Shimizu S; Masuda K; Asanuma T; Okabe H; Nakatani S
Echocardiography; 2015 Apr; 32(4):623-9. PubMed ID: 25115860
[TBL] [Abstract][Full Text] [Related]
8. B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction.
van Veldhuisen DJ; Linssen GC; Jaarsma T; van Gilst WH; Hoes AW; Tijssen JG; Paulus WJ; Voors AA; Hillege HL
J Am Coll Cardiol; 2013 Apr; 61(14):1498-506. PubMed ID: 23500300
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of bedside tissue Doppler echocardiography and B-type natriuretic peptide (BNP) in differentiating congestive heart failure from noncardiac cause of acute dyspnea in elderly patients with a normal left ventricular ejection fraction and permanent, nonvalvular atrial fibrillation: insights from a prospective, monocenter study.
Arques S; Roux E; Sbragia P; Pieri B; Gelisse R; Luccioni R; Ambrosi P
Echocardiography; 2007 May; 24(5):499-507. PubMed ID: 17456069
[TBL] [Abstract][Full Text] [Related]
10. Assessing strategies for heart failure with preserved ejection fraction at the outpatient clinic.
Jorge AJ; Rosa ML; Ribeiro ML; Fernandes LC; Freire MD; Correia DS; Teixeira PD; Mesquita ET
Arq Bras Cardiol; 2014 Sep; 103(3):231-7. PubMed ID: 25119893
[TBL] [Abstract][Full Text] [Related]
11. Optimal noninvasive assessment of diastolic heart failure in patients with atrial fibrillation: comparison of tissue doppler echocardiography, left atrium size, and brain natriuretic peptide.
Watanabe T; Iwai-Takano M; Oikawa M; Yamaki T; Yaoita H; Maruyama Y
J Am Soc Echocardiogr; 2008 Jun; 21(6):689-96. PubMed ID: 17904810
[TBL] [Abstract][Full Text] [Related]
12. B-Type Natriuretic Peptide in Heart Failure With Preserved Ejection Fraction - Relevance to Age-Related Left Ventricular Modeling in Japanese.
Harada E; Mizuno Y; Kugimiya F; Shono M; Maeda H; Yano N; Kuwahara K; Yasue H
Circ J; 2017 Jun; 81(7):1006-1013. PubMed ID: 28381705
[TBL] [Abstract][Full Text] [Related]
13. Prevalence, clinical phenotype, and outcomes associated with normal B-type natriuretic peptide levels in heart failure with preserved ejection fraction.
Anjan VY; Loftus TM; Burke MA; Akhter N; Fonarow GC; Gheorghiade M; Shah SJ
Am J Cardiol; 2012 Sep; 110(6):870-6. PubMed ID: 22681864
[TBL] [Abstract][Full Text] [Related]
14. Screening for asymptomatic heart failure with preserved ejection fraction in mongolian population at high risk.
Unurjargal T; Khorloo C; Ulziisaikhan G; Sodovsuren N; Khasag A
Kardiologiia; 2020 Mar; 60(4):86-90. PubMed ID: 32394862
[TBL] [Abstract][Full Text] [Related]
15. New echocardiographic predictors of clinical outcome in patients presenting with heart failure and a preserved left ventricular ejection fraction: a subanalysis of the Ka (Karolinska) Ren (Rennes) Study.
Donal E; Lund LH; Oger E; Hage C; Persson H; Reynaud A; Ennezat PV; Bauer F; Drouet E; Linde C; Daubert C;
Eur J Heart Fail; 2015 Jul; 17(7):680-8. PubMed ID: 26033771
[TBL] [Abstract][Full Text] [Related]
16. Adaptive cardiovascular hormones in a spectrum of heart failure phenotypes.
Zabarovskaja S; Hage C; Linde C; Daubert JC; Donal E; Gabrielsen A; Mellbin L; Lund LH
Int J Cardiol; 2015; 189():6-11. PubMed ID: 25885866
[TBL] [Abstract][Full Text] [Related]
17. [Utility of B-type natriuretic peptide measurement in outpatients with heart failure with preserved ejection fraction].
Jorge AJ; Freire MD; Ribeiro ML; Fernandes LC; Lanzieri PG; Jorge BA; Lage JG; Rosa ML; Mesquita ET
Rev Port Cardiol; 2013 Sep; 32(9):647-52. PubMed ID: 23910641
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA signatures differentiate preserved from reduced ejection fraction heart failure.
Watson CJ; Gupta SK; O'Connell E; Thum S; Glezeva N; Fendrich J; Gallagher J; Ledwidge M; Grote-Levi L; McDonald K; Thum T
Eur J Heart Fail; 2015 Apr; 17(4):405-15. PubMed ID: 25739750
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of tissue Doppler echocardiography in the emergency diagnosis of decompensated heart failure with preserved left ventricular systolic function: comparison with B-type natriuretic peptide measurement.
Arques S; Roux E; Sbragia P; Ambrosi P; Taieb L; Pieri B; Gelisse R; Luccioni R
Echocardiography; 2005 Sep; 22(8):657-64. PubMed ID: 16174119
[TBL] [Abstract][Full Text] [Related]
20. Natriuretic peptide-based screening and collaborative care for heart failure: the STOP-HF randomized trial.
Ledwidge M; Gallagher J; Conlon C; Tallon E; O'Connell E; Dawkins I; Watson C; O'Hanlon R; Bermingham M; Patle A; Badabhagni MR; Murtagh G; Voon V; Tilson L; Barry M; McDonald L; Maurer B; McDonald K
JAMA; 2013 Jul; 310(1):66-74. PubMed ID: 23821090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
